Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Young professionals can benefit from smart wealth building tips. Implement these strategies to secure a prosperous financial future.
11,767 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A leading south korean digital bank launches a Solana-based PoC to move funds across borders, testing stablecoin remi...
Chainlink announces a landmark cross-border banking pact linking European and Korean lenders to test instant FX settl...
A thoughtful look at what a July price milestone could mean for SpaceX in a hypothetical IPO scenario. Learn how to a...
SoftBank dismisses Elon Musk’s orbital data center idea, choosing immediate Earth-based expansion. The move comes as ...
A UK Parliament submission proposes using the XRP Ledger as the settlement layer for a new climate-financing instrume...
The DATA Foundation rebrands and unveils DATA Network with Trace, a bold bid to solve the AI training data bottleneck...
A simple computer moment can signal bigger trouble. This article explains how a watched mouse move laptop moment can ...
RFK Jr. floated a plan to raise payroll taxes by about one-third to close Social Security's funding gap, a move that ...
A new ETF strategy shifts focus from AI chipmakers to the data-center buildout, charging 0.47% and backing the compan...